Johannes W. Smit

Nijmegen, GE, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Digoxin treatment does not reinduce radioiodine uptake in radioiodine refractory non-medullary thyroid carcinoma.

Digoxin treatment does not reinduce radioiodine uptake in radioiodine refractory non-medullary thyroid carcinoma.

Journal: European thyroid journal

Published: May 13, 2024

Differentiated thyroid carcinoma: An update.

Differentiated thyroid carcinoma: An update.

Journal: Best practice & research. Clinical endocrinology & metabolism

Published: August 24, 2022

2022 ETA Consensus Statement: What are the indications for post-surgical radioiodine therapy in differentiated thyroid cancer?

2022 ETA Consensus Statement: What are the indications for post-surgical radioiodine therapy in differentiated thyroid cancer?

Journal: European thyroid journal

Published: September 10, 2021

Efficacy of liraglutide on glycemic endpoints in people of Western European and South Asian descent with T2DM using multiple daily insulin injections: results of the MAGNA VICTORIA studies.

Efficacy of liraglutide on glycemic endpoints in people of Western European and South Asian descent with T2DM using multiple daily insulin injections: results of the MAGNA VICTORIA studies.

Journal: Acta diabetologica

Published: October 10, 2020

The Effect of Glycemic Control on Renal Triglyceride Content Assessed by Proton Spectroscopy in Patients With Type 2 Diabetes Mellitus: A Single-Center Parallel-Group Trial.

The Effect of Glycemic Control on Renal Triglyceride Content Assessed by Proton Spectroscopy in Patients With Type 2 Diabetes Mellitus: A Single-Center Parallel-Group Trial.

Journal: Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation

Published: April 20, 2020

Placebo-controlled randomised trial with liraglutide on magnetic resonance endpoints in individuals with type 2 diabetes: a pre-specified secondary study on ectopic fat accumulation.

Placebo-controlled randomised trial with liraglutide on magnetic resonance endpoints in individuals with type 2 diabetes: a pre-specified secondary study on ectopic fat accumulation.

Journal: Diabetologia

Published: June 07, 2019

Insights into the role of IL-32 in cancer.

Insights into the role of IL-32 in cancer.

Journal: Seminars in immunology

Published: November 22, 2017

Pathological processes and therapeutic advances in radioiodide refractory thyroid cancer.

Pathological processes and therapeutic advances in radioiodide refractory thyroid cancer.

Journal: Journal of molecular endocrinology

Published: September 12, 2017

Association of NF-κB polymorphisms with clinical outcome of non-medullary thyroid carcinoma.

Association of NF-κB polymorphisms with clinical outcome of non-medullary thyroid carcinoma.

Journal: Endocrine-related cancer

Published: March 30, 2017

Rare NOX3 Variants Confer Susceptibility to Agranulocytosis During Thyrostatic Treatment of Graves' Disease.

Rare NOX3 Variants Confer Susceptibility to Agranulocytosis During Thyrostatic Treatment of Graves' Disease.

Journal: Clinical pharmacology and therapeutics

Published: February 15, 2017

Postural orthostatic tachycardia is not a useful diagnostic marker for chronic fatigue syndrome.

Postural orthostatic tachycardia is not a useful diagnostic marker for chronic fatigue syndrome.

Journal: Journal of internal medicine

Published: October 04, 2016

Multifocality in Sporadic Medullary Thyroid Carcinoma: An International Multicenter Study.

Multifocality in Sporadic Medullary Thyroid Carcinoma: An International Multicenter Study.

Journal: Thyroid : official journal of the American Thyroid Association

Published: September 09, 2016

Showing 1-12 of 27

Last Updated: 09/26/2026